Torrate, Eunice .
HRN: 05-12-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/07/2024
10/09/2024
IVT
500mg
Q8hrs
S/p CS With IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes